SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-083784
Filing Date
2020-07-15
Accepted
2020-07-15 17:00:40
Documents
2
Period of Report
2020-07-14

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 18294
2 EX-99.1 ex-99d1.htm EX-99.1 8930
  Complete submission text file 0001104659-20-083784.txt   29376
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Issuer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2 HARBOUR SQUARE CROFTON ROAD DUN LAOGHAIRE, CO. DUBLIN L2 -----
Business Address 2 HARBOUR SQUARE CROFTON ROAD DUN LAOGHAIRE, CO. DUBLIN L2 ----- 353 1 901 5701
Malin Corp plc (Reporting) CIK: 0001673063 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39376 | Film No.: 201030024

Mailing Address 2 HARBOUR SQUARE CROFTON ROAD DUN LAOGHAIRE, CO, DUBLIN L2 ----
Business Address 2 HARBOUR SQUARE CROFTON ROAD DUN LAOGHAIRE, CO, DUBLIN L2 ---- 353 1 901 5701
Malin Life Sciences Holdings Ltd (Reporting) CIK: 0001685138 (see all company filings)

State of Incorp.: L2 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39376 | Film No.: 201030023